Escalator, water ATM: Mansa Devi temple visit set to get smoother for devotees

The Delhi High Court is reviewing Natco Pharma’s challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two patents for the same invention. This action, Natco claims, unlawfully extends patent protection for the Ribociclib molecule. The court will first determine the petition’s maintainability after legal arguments. The case has been scheduled…

Above SMA 20

In keeping with the spirit of Jan Vishwas, ease of living, and to reduce the burden of litigation and compliance, Budget 2026 has proposed changes related to the filing of ITR.